Inside Dr. Daniel Heller’s Lab
Inside Dr. Daniel Heller’s Lab at Memorial Sloan Cancer Center you will find scientists and researchers that specialize in Nanomedicine inventing novel technologies to treat advanced cancers and to detect disease at early stages. They are a young bioengineering laboratory that develops new nanotechnologies, including nanomedicines—tiny particles that target drugs to tumor sites, and nanosensors—tiny devices that detect markers of disease.
This lab is developing nanomedicines to target precision agents to disease sites, including to metastatic cancers. Inside Dr. Heller’s Lab they are also addressing the problem of the early detection of cancer and other diseases by building implantable nanosensors. To enable the discovery of new medicines, they are also inventing new nanosensors and imaging tools to accelerate drug development and biomedical research.
About EMF’s Research Fund
The Expect Miracles Research Fund supports The Center for Experimental Therapeutics at Memorial Sloan Kettering in New York City, a critical research collaborative working to hasten the time it takes to get new, more effective and less toxic therapies to cancer patients. The fund specifically supports the research of The Daniel Heller, PhD Research Lab which develops nanotechnologies to treat metastatic cancers and to detect disease at early stages.